Evidence map›Paper›PMID 31210642›Full record

ArticleeLife2019

Family history of Alzheimer's disease alters cognition and is modified by medical and genetic factors.

Joshua S Talboom, Asta Håberg, Matthew D De Both, Marcus A Naymik, Isabelle Schrauwen, Candace R Lewis, Stacy F Bertinelli, Callie Hammersland, Mason A Fritz, Amanda J Myers and 5 more

Abstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. A novel composite biomarker score for the identification of cognitive impairment in patients with heart failure: a pilot study.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2025
    Article
  4. Personalized prevention of neurodegenerative diseases: scoping review and evidence gap map.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in neuroscience · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Joshua S TalboomThe Translational Genomics Research Institute, Phoenix, United States.ORCID 0000-0002-4327-4103
Asta HåbergNorwegian University of Science and Technology, Trondheim, Norway.
Matthew D De BothThe Translational Genomics Research Institute, Phoenix, United States.
Marcus A NaymikThe Translational Genomics Research Institute, Phoenix, United States.
Isabelle SchrauwenThe Translational Genomics Research Institute, Phoenix, United States.
Candace R LewisThe Translational Genomics Research Institute, Phoenix, United States.
Stacy F BertinelliThe Translational Genomics Research Institute, Phoenix, United States.
Callie HammerslandThe Translational Genomics Research Institute, Phoenix, United States.
Mason A FritzThe Translational Genomics Research Institute, Phoenix, United States.
Amanda J MyersUniversity of Miami, Miami, United States.
Meredith HayArizona Alzheimer's Consortium, Phoenix, United States.
Carol A BarnesArizona Alzheimer's Consortium, Phoenix, United States.
Elizabeth GliskyArizona Alzheimer's Consortium, Phoenix, United States.
Lee RyanArizona Alzheimer's Consortium, Phoenix, United States.
Matthew J HuentelmanThe Translational Genomics Research Institute, Phoenix, United States.ORCID 0000-0001-7390-9918

Funding

Neural System Dynamics & Gene Expression Supporting Successful Cognitive AgingR01AG049465 · NIA · UNIVERSITY OF ARIZONA · PI BARNES, CAROL A. · 2014 to 2018
$3.6M
APOEomic: Searching for APOE interacting risk factors using omics dataR01AG041232 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HUENTELMAN, MATT, MYERS, AMANDA J · 2013 to 2017
$1.7M
Arizona Department of Health Services Arizona DHS in support of the Arizona Alzheimer's ConsortiumNIA NIH HHS R01 AG041232NIA NIH HHS R01 AG049465NIH HHS R01- AG041232NIH HHS R01-AG049465-05
6 · The paper itself

Abstract

In humans, a first-degree family history of dementia (FH) is a well-documented risk factor for Alzheimer's disease (AD); however, the influence of FH on cognition across the lifespan is poorly understood. To address this issue, we developed an internet-based paired-associates learning (PAL) task and tested 59,571 participants between the ages of 18-85. FH was associated with lower PAL performance in both sexes under 65 years old. Modifiers of this effect of FH on PAL performance included age, sex, education, and diabetes. The Apolipoprotein E ε4 allele was also associated with lower PAL scores in FH positive individuals. Here we show, FH is associated with reduced PAL performance four decades before the typical onset of AD; additionally, several heritable and non-heritable modifiers of this effect were identified.

Indexed as

CognitionAdolescentAdultAgedAged, 80 and overAllelesAlzheimer DiseaseApolipoprotein E4Educational StatusFemaleHumansLearningMaleMiddle AgedYoung AdultApolipoprotein E4Alzheimer's DiseaseApolipoprotein E (APOE)dementiafamily historyhumanhuman biologyinternet-basedmedicineneurosciencepaired-associates learning

Identifiers

PMID31210642
PMCPMC6615857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.